IMC-Chicago, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$1,017,520
-37.6%
11,500
-38.8%
0.00%0.0%
Q2 2023$1,629,584
-39.9%
18,800
-32.6%
0.00%
-66.7%
Q1 2023$2,712,996
-27.6%
27,900
-22.9%
0.00%
-50.0%
Q4 2022$3,746,338
+253.4%
36,200
+189.6%
0.01%
+500.0%
Q3 2022$1,060,000
-47.2%
12,500
-44.9%
0.00%
-50.0%
Q4 2021$2,006,000
-59.1%
22,700
-61.4%
0.00%
-66.7%
Q2 2021$4,906,000
+12.6%
58,800
+1.9%
0.01%0.0%
Q1 2021$4,357,000
-22.6%
57,700
-10.1%
0.01%
-14.3%
Q4 2020$5,630,000
+345.8%
64,200
+286.7%
0.01%
+250.0%
Q3 2020$1,263,00016,6000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2021
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 2,027$17,774,0000.02%
Hudson Bay Capital Management LP 40,000$3,508,0000.02%
GROUP ONE TRADING, L.P. 103,800$9,102,0000.02%
IMC-Chicago, LLC 64,200$5,630,0000.01%
JPMORGAN CHASE & CO 353,400$30,990,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders